Discontinuation report METOJECT
Report ID | 164145 |
Drug Identification Number | 02320029 |
Brand name | METOJECT |
Common or Proper name | Methotrexate sodium solution for injection |
Company Name | MEDEXUS PHARMACEUTICALS INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 7.5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL |
Packaging size | 1 PFS |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | 2022-07-01 |
Actual discontinuation date | 2022-06-29 |
Remaining supply date | 2022-06-23 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Limited supply at wholesaler level |
Company comments | Manufacturer is no longer producing the Metoject 7.5mg/0.75mL |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 35 NIXON ROAD, UNIT 10 BOLTON, ONTARIO CANADA L7E 1K1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-07-05 | French | Compare |
v1 | 2022-07-05 | English | Compare |
Showing 1 to 2 of 2